Loading
Precision Scientific
Precision Scientific provides drug mechanism research services for pharmaceutical and biotechnology companies. The company's self-developed cutting-edge AI technology ALBERT (AI-driven Big data analytics for Effective Response of cancer Therapy) is a machine learning-based analysis of multi-omics data using data mining and predictive algorithms to provide solutions for oncology research, including drug target discovery, biomarker identification, indication selection, drug resistance mechanism evaluation, and combo therapy strategy.
Funding
Every round, secondary, debt facility or acquisition involving Precision Scientific that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—